Literature DB >> 23991726

Eltrombopag and serum of a different hue.

David Cardamone, Michael C Milone, Laurel Glaser, Noelle V Frey, Larry J Kricka.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23991726     DOI： 10.5858/arpa.2012-0716-LE

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  4 in total

1.  Eltrombopag mobilizes iron in patients with aplastic anemia.

Authors:  Zhen Zhao; Qian Sun; Lori J Sokoll; Michael Streiff; Zhe Cheng; Sophie Grasmeder; Danielle M Townsley; Neal S Young; Cynthia E Dunbar; Thomas Winkler
Journal:  Blood       Date:  2018-04-09       Impact factor: 22.113

2.  Transfusion medicine illustrated: Muddy waters in therapeutic plasma exchange.

Authors:  Kamille A West; Susan F Leitman; Willy A Flegel
Journal:  Transfusion       Date:  2014-09       Impact factor: 3.157

3.  Interference of eltrombopag with bilirubin measurements on the Vitros 5600 analyzer.

Authors:  Izmarie Poventud-Fuentes; Emily Garnett; Jenny Despotovic; Sridevi Devaraj
Journal:  J Clin Lab Anal       Date:  2021-06-19       Impact factor: 2.352

4.  Eltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survival.

Authors:  Anna Kalota; Mary A Selak; Laura A Garcia-Cid; Martin Carroll
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.